There are 3163 resources available
1208MO - Phase III trial of perioperative pirfenidone therapy for lung cancer with idiopathic pulmonary fibrosis (IPF): NEJ034 study
Presenter: Yukinobu Goto
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
Slides
Webcast
1143O - Refining molecular classification of neuroendocrine tumors from diverse origins using multi-omic integration models: Unveiling novel neuroendocrine subtypes and their clinical implications
Presenter: Carlos Carretero-Puche
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
68O - Frequency of clinical acquired RAS-MAPK pathway resistance alterations in patients treated with KRASG12C inhibitors: An individual patient meta-analysis
Presenter: Jakob Riedl
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Abstract
Slides
Webcast
What about long-term toxicities?
Presenter: Eleonora Ghisoni
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
AI and machine learning to identify early phase clinical trial biomarkers
Presenter: Jakob Kather
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Discussion
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Webcast
Novel systemic therapeutic approaches in mCRC
Presenter: Maria Elena Elez Fernandez
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
Patients with liver metastases
Presenter: René Adam
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
Discussion
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Webcast
Q&A and discussion
Session: Treatment of difficult lymphomas
Resources:
Webcast